Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
Public ClinicalTrials.gov record NCT05700994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.
Study identification
- NCT ID
- NCT05700994
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,283 participants
Conditions and interventions
Conditions
Interventions
- Peer Contingency Management Behavioral
- Standard of Care Contingency Management Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 105 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2023
- Primary completion
- Sep 29, 2026
- Completion
- Sep 29, 2026
- Last update posted
- Jan 13, 2026
2023 – 2026
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comagine Health | Portland | Oregon | 97232 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Methamphetamine Abuse trials
Other public records listing Methamphetamine Abuse. Sorted by last update posted; newest first. Not a recommendation.
- NCT06721494: A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine Recruiting
- NCT06233799: Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder Recruiting
- NCT06496750: Ketamine for Methamphetamine Use Disorder Recruiting
- NCT05521854: Contingency Management for Drug Use: Does Age Matter? Active, not recruiting
- NCT04927143: Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives Recruiting
- NCT03470480: rTMS for Craving in Methamphetamine Use Disorder Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05700994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2026 · Synced Jul 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05700994 live on ClinicalTrials.gov.